Task Group 174 Report: Utilization of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography ([ 18 F]FDG-PET) in Radiation Therapy
| Autor: | Yusuf E. Erdi, Fang-Fang Yin, Paul E. Kinahan, Heiko Schöder, Ronald Boellaard, Lei Xing, Stephen R. Bowen, Daniel C. Sullivan, Jeffrey D. Bradley, Osama Mawlawi, Sasa Mutic, James E. Bowsher, R McGurk, Moyed Miften, Shiva K. Das, John E. Bayouth |
|---|---|
| Přispěvatelé: | Radiology and nuclear medicine, ACS - Heart failure & arrhythmias, Amsterdam Neuroscience - Brain Imaging, CCA - Imaging and biomarkers |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Task group
medicine.medical_specialty medicine.diagnostic_test business.industry medicine.medical_treatment Image registration Glucose analog General Medicine 030218 nuclear medicine & medical imaging Radiation therapy 03 medical and health sciences 0302 clinical medicine Positron emission tomography 030220 oncology & carcinogenesis Medicine Medical physics 18 f fluorodeoxyglucose business Radiation treatment planning Quality assurance |
| Zdroj: | Medical Physics, 46(10), e706-e725. AAPM-American Association of Physicists in Medicine Das, S K, McGurk, R, Miften, M, Sasa, M, Bowsher, J, Bayouth, J, Erdi, Y, Mawlawi, O, Boellaard, R, Bowen, S R, Xing, L, Bradley, J, Schoder, H, Yin, F-F, Sullivan, D C & Kinahan, P 2019, ' Task Group 174 Report: Utilization of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography ([ 18 F]FDG-PET) in Radiation Therapy ', Medical Physics, vol. 46, no. 10, pp. e706-e725 . https://doi.org/10.1002/mp.13676 |
| ISSN: | 0094-2405 |
| DOI: | 10.1002/mp.13676 |
| Popis: | The use of positron emission tomography (PET) in radiation therapy (RT) is rapidly increasing in the areas of staging, segmentation, treatment planning, and response assessment. The most common radiotracer is 18F-fluorodeoxyglucose ([ 18F]FDG), a glucose analog with demonstrated efficacy in cancer diagnosis and staging. However, diagnosis and RT planning are different endeavors with unique requirements, and very little literature is available for guiding physicists and clinicians in the utilization of [ 18F]FDG-PET in RT. The two goals of this report are to educate and provide recommendations. The report provides background and education on current PET imaging systems, PET tracers, intensity quantification, and current utilization in RT (staging, segmentation, image registration, treatment planning, and therapy response assessment). Recommendations are provided on acceptance testing, annual and monthly quality assurance, scanning protocols to ensure consistency between interpatient scans and intrapatient longitudinal scans, reporting of patient and scan parameters in literature, requirements for incorporation of [ 18F]FDG-PET in treatment planning systems, and image registration. The recommendations provided here are minimum requirements and are not meant to cover all aspects of the use of [ 18F]FDG-PET for RT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text